Literature DB >> 25687460

Isoform-selective histone deacetylase inhibitors: the trend and promise of disease treatment.

Yingjie Zhang1, Wenfang Xu.   

Abstract

Keywords:  HDAC1; HDAC3; Huntington's disease; epigenetics; neurodegenerative disease; selective inhibitors; tumor

Mesh：

Substances：

Year:  2015        PMID： 25687460     DOI： 10.2217/epi.14.62

Source DB:  PubMed          Journal:  Epigenomics        ISSN： 1750-192X            Impact factor:   4.778


× No keyword cloud information.
  3 in total

1.  A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma.

Authors:  Belamy B Cheung; Ane Kleynhans; Rituparna Mittra; Patrick Y Kim; Jessica K Holien; Zsuzsanna Nagy; Olivia C Ciampa; Janith A Seneviratne; Chelsea Mayoh; Mukesh Raipuria; Satyanarayana Gadde; Hassina Massudi; Iris Poh Ling Wong; Owen Tan; Andrew Gong; Aldwin Suryano; Sonya M Diakiw; Bing Liu; Greg M Arndt; Tao Liu; Naresh Kumar; Olle Sangfelt; Shizhen Zhu; Murray D Norris; Michelle Haber; Daniel R Carter; Michael W Parker; Glenn M Marshall
Journal:  Oncogene       Date:  2021-03-03       Impact factor: 8.756

2.  Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety.

Authors:  Hue Thi Buu Bui; Phuong Hong Nguyen; Quan Minh Pham; Hoa Phuong Tran; De Quang Tran; Hosun Jung; Quang Vinh Hong; Quoc Cuong Nguyen; Quy Phu Nguyen; Hieu Trong Le; Su-Geun Yang
Journal:  Molecules       Date:  2022-03-28       Impact factor: 4.411

Review 3.  Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms.

Authors:  Lichuan Wu; Ke Ye; Sheng Jiang; Guangbiao Zhou
Journal:  Mar Drugs       Date:  2021-08-27       Impact factor: 5.118
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.